MHRA announces corporate plan for 2023-2026
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring a focus on patient access to innovation.
#drugapprovals
Tag
NICE invites feedback on health technology evaluations manual
The UK’s National Institute for Health and Care Excellence (NICE) has opened a public consultation on the first updates to its health technology evaluations manual, which was published in January 2022.
NICE develops proportionate approach to technology appraisals
The National Institute for Health and Care Excellence (NICE) plans to speed up its processes for evaluating lower-risk treatments using a lighter touch approach. This will free up time to consider the increasing number of more complex applications. NICE states that this method will make its assessments faster, enabling quicker access to promising new treatments.